Long-term systemic use is concerning for copper balance, as copper deficiency has been linked to neurodegenerative disorders and even excess copper is risky
Additionally, obesity can lead to significant psychosocial issues, including stigma, psychological illness, and reduced quality of life
Anecdotal reports suggest that microdosing could slow aging-related declines in health
Additional research is exploring tirzepatide potential benefits for Alzheimer disease, where insulin resistance and neuroinflammation play pathogenic roles
My takeaway The obesity treatment landscape is entering a new phase of competition oral GLP-1 therapies
A new triple-action weekly jab for type 2 diabetes could significantly reduce blood sugar and body weight, according to phase 3 trial results